Sign up to save your podcasts
Or
Share New Treatment for IDH mt Gliomas
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Treatment for IDH mt Gliomas
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
315 Listeners
Practical Neurology Podcast
47 Listeners
JAMA Clinical Reviews
496 Listeners
The Curbsiders Internal Medicine Podcast
3,316 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,103 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
518 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
365 Listeners
Continuum Audio
78 Listeners